A novel pharmaceutical composition for the treatment of dry eye syndrome

摘要

The present invention provides a novel pharmaceutical composition for the treatment of dry eye syndrome, which effectively treats ophthalmic diseases related to dry eye disease by significantly improving corneal damage and corneal opacity without side effects, thereby restoring the damaged cornea and increasing tear secretion.